Joanne M. Donovan's Net Worth
$452 Thousand
Who is Joanne M. Donovan?
Joanne M. Donovan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Edgewise Therapeutics, Inc., and CATABASIS PHARMACEUTICALS INC.
SEC CIK
Joanne M. Donovan's CIK is 0001644087
Past Insider Trading and Trends
2016 was Joanne M. Donovan's most active year for acquiring shares with 3 total transactions. Joanne M. Donovan's most active month to acquire stocks was the month of January. 2023 was Joanne M. Donovan's most active year for disposing of shares, totalling 2 transactions. Joanne M. Donovan's most active month to dispose stocks was the month of April. 2022 saw Joanne M. Donovan paying a total of $0.00 for 271,250 shares, this is the most they've acquired in one year. In 2024 Joanne M. Donovan cashed out on 14,099 shares for a total of $69,626.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Edgewise Therapeutics, Inc. (EWTX) Snapshot price: $17.52
CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -33.00% | -7.16K |
$28.29 | -$202,602.95 | 14.54K |
Sep 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
| +51.17% | 6.74K |
$18.91 | -$69,626.62 | 19.9K |
May 1 - May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
| +255.97% | 7.16K |
$8.90 | -$28,976.54 | 9.96K |
May 1 - May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CATABASIS PHARMACEUTICALS INC (ATXS) Snapshot price: $11.12
CMO; SVP Clinical Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 11
| |||
Form 4
|
∞
| 409 |
—
|
—
| 409 |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |